A $1.8 billion Anthropic deal and a BofA upgrade rewrote this company's story in one quarter.
Day: July 8, 2026
Gilead Is Up 3.5% Today. Regeneron Is Down 40% From Its High.
Same biopharma category. One is quietly building something the market is missing.